- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Bernstein maintains agilon health stock rating, cites 2026 outlook | 2 | Investing.com | ||
| 02.04. | Benchmark raises agilon health stock price target on reverse split | 1 | Investing.com | ||
| 30.03. | agilon health, inc. - 8-K, Current Report | - | SEC Filings | ||
| 18.03. | agilon health announces 1-for-25 reverse stock split | 1 | Seeking Alpha | ||
| AGILON HEALTH Aktie jetzt für 0€ handeln | |||||
| 18.03. | agilon health, inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 18.03. | agilon health, Inc. Announces Reverse Stock Split | 178 | Business Wire | WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL) (the "Company"), the trusted partner empowering physicians to transform health care in our communities, today announced that it will... ► Artikel lesen | |
| 26.02. | agilon health Q4 2025 slides: path to breakeven after $296M loss | 2 | Investing.com | ||
| 25.02. | Agilon Health: Umsatz übertrifft Erwartungen trotz höherem Verlust - Aktie legt kräftig zu | 2 | Investing.com Deutsch | ||
| 25.02. | agilon health GAAP EPS of -$0.46 misses by $0.19, revenue of $1.57B beats by $110M | 2 | Seeking Alpha | ||
| 25.02. | Agilon Health: Q4 Earnings Insights | 1 | Benzinga.com | ||
| 25.02. | agilon health, inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 25.02. | agilon health, inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.02. | agilon health, inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 04.02. | Block & Leviton LLP: AGL: Investors Who Lost Money In Agilon Health Stock Should Contact Block & Leviton By March 2nd To Potentially Recover Losses | 410 | Newsfile | Boston, Massachusetts--(Newsfile Corp. - February 4, 2026) - Block & Leviton reminds investors that a securities fraud lawsuit has been filed against agilon health, inc. (NYSE: AGL) and certain... ► Artikel lesen | |
| 14.01. | Block & Leviton LLP: Securities Fraud Lawsuit Could Allow Agilon Health Investors to Recover Losses; Block & Leviton Encourages Shareholders to Contact the Firm | 587 | Newsfile | Boston, Massachusetts--(Newsfile Corp. - January 14, 2026) - Block & Leviton reminds investors that a securities fraud lawsuit has been filed against agilon health, inc. (NYSE: AGL) and certain... ► Artikel lesen | |
| 07.01. | agilon health, inc. - 8-K, Current Report | - | SEC Filings | ||
| 07.11.25 | Aktie von agilon health fällt nach NYSE-Mitteilung über Nichterfüllung der Börsenzulassungsregeln | 2 | Investing.com Deutsch | ||
| 07.11.25 | agilon health plant Reverse-Split zur Erfüllung der NYSE-Börsenanforderungen | 4 | Investing.com Deutsch | ||
| 07.11.25 | agilon health, inc. - 8-K, Current Report | - | SEC Filings | ||
| 05.11.25 | Agilon health reinstates $5.82B revenue guidance for 2025 while streamlining cost base | 2 | Seeking Alpha |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 46,010 | 0,00 % | BrightSpring Health Services, Inc.: BrightSpring Health Services Completes Sale of ResCare Community Living to Sevita | LOUISVILLE, Ky., March 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based pharmacy and... ► Artikel lesen | |
| GERRESHEIMER | 20,740 | +17,18 % | Gerresheimer muss SDAX verlassen - exotischer Nachrücker | Es hat sich bereits abgezeichnet: Der angeschlagene Spezialverpackungshersteller Gerresheimer muss den SDAX bereits zum morgigen 10. April verlassen. Die Düsseldorfer haben es versäumt, den testierten... ► Artikel lesen | |
| BILLIONTOONE | 80,61 | 0,00 % | BillionToOne, Inc.: BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026 | ||
| FRESENIUS | 44,240 | +0,48 % | FRESENIUS SE & CO KGAA: Struktur in der Ruhe | ||
| FRESENIUS MEDICAL CARE | 38,650 | -0,10 % | Shortseller-Positionen aktuell: u.a. Carl Zeiss Meditec, Evonik, FMC, Gerresheimer, GFT, MTU, Nordex, Ströer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,260 | -0,21 % | SIEMENS HEALTHINEERS AG im strategischen Gleichgewicht | ||
| BETA BIONICS | 13,020 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 | IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| HEARTFLOW | 29,190 | 0,00 % | Heartflow, Inc.: Heartflow Files Patent Infringement Lawsuit Against Cleerly | MOUNTAIN VIEW, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that it has filed... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 25,700 | 0,00 % | PROCEPT BioRobotics to Report First Quarter 2026 Financial Results on April 29, 2026 | ||
| HIMS & HERS HEALTH | 22,180 | +7,67 % | Hims & Hers-Aktie: Neue Chancen nach dem Hype? | Die Aktie von Hims & Hers Health hat nach einer Zeit voller Hype und überschwänglichen Erwartungen in den vergangenen Monaten massiv gelitten. Nach einem deutlichen Kursrückgang rückt nun die Frage... ► Artikel lesen | |
| GENEDX | 67,32 | 0,00 % | Jefferies bestätigt Kaufempfehlung für GeneDx und verweist auf geringe Marktdurchdringung | ||
| PROGYNY | 17,400 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,920 | 0,00 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 6,290 | 0,00 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Notification regarding unquoted securities - AVR | ||
| RXSIGHT | 7,215 | 0,00 % | RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer | ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen |
AGILON HEALTH INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 26,930 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AGILON HEALTH INC finden Sie auf Wallstreet Online.